Literature DB >> 23498679

Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome.

Kenichiro Otsuka1, Shota Fukuda, Atsushi Tanaka, Koki Nakanishi, Haruyuki Taguchi, Junichi Yoshikawa, Kenei Shimada, Minoru Yoshiyama.   

Abstract

OBJECTIVES: The aim of this study was to determine the predictive value of the napkin-ring sign on coronary computed tomography angiography (CTA) for future acute coronary syndrome (ACS) events in patients with coronary artery disease.
BACKGROUND: Recent studies have reported a close association between the napkin-ring sign on coronary CTA and thin-cap fibroatheroma.
METHODS: The subjects of this prospective study were 895 consecutive patients who underwent coronary CTA examination and were followed for >1 year. The primary endpoint was an ACS event (cardiac death, nonfatal myocardial infarction, or unstable angina pectoris). The coronary CTA analysis included the presence of obstructive plaque, positive remodeling (PR), low-attenuation plaque (LAP), and the napkin-ring sign. The napkin-ring sign was defined by the following criteria: 1) the presence of a ring of high attenuation around certain coronary artery plaques; and 2) attenuation of the ring presenting higher than those of the adjacent plaque and no >130 Hounsfield units.
RESULTS: Of the 12,727 segments, 1,174 plaques were observed, including plaques with PR in 130 segments (1.0%), LAP in 107 segments (0.8%), and napkin-ring signs in 45 segments (0.4%). Thirty-six of the 45 plaques with napkin-ring signs (80%) overlapped with those showing either PR or LAP. During the follow-up period (2.3 ± 0.8 years), 24 patients (2.6%) experienced ACS events, and plaques developed in 41% with a napkin-ring sign. Segment-based Cox proportional hazards models analysis showed that PR (p < 0.001), LAP (p = 0.007), and the napkin-ring sign (p < 0.0001) were independent predictive factors for future ACS events. Kaplan-Meier analysis demonstrated that plaques with napkin-ring signs showed a higher risk of ACS events compared with those without a napkin-ring sign.
CONCLUSIONS: The present study demonstrated for the first time that the napkin-ring sign demonstrated on coronary CTA was strongly associated with future ACS events, independent of other high-risk coronary CTA features. Detection of the napkin-ring sign could help identify coronary artery disease patients at high risk of future ACS events.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23498679     DOI: 10.1016/j.jcmg.2012.09.016

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  85 in total

Review 1.  MDCT evaluation of atherosclerotic coronary artery disease: what should radiologists know?

Authors:  Hye Rin Kim; Seung Min Yoo; Ji Young Rho; Hwa Yeon Lee; Charles S White
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-01       Impact factor: 2.357

Review 2.  Emerging Role of Coronary Computed Tomography Angiography in Lipid-Lowering Therapy: a Bridge to Image-Guided Personalized Medicine.

Authors:  Toru Miyoshi; Kazuhiro Osawa; Keishi Ichikawa; Kazuki Suruga; Takashi Miki; Masashi Yoshida; Koji Nakagawa; Hironobu Toda; Kazufumi Nakamura; Hiroshi Morita; Hiroshi Ito
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

Review 3.  Cardiac hybrid imaging.

Authors:  Oliver Gaemperli; Philipp A Kaufmann; Hatem Alkadhi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05       Impact factor: 9.236

4.  Coronary Atherosclerotic Precursors of Acute Coronary Syndromes.

Authors:  Hyuk-Jae Chang; Fay Y Lin; Sang-Eun Lee; Daniele Andreini; Jeroen Bax; Filippo Cademartiri; Kavitha Chinnaiyan; Benjamin J W Chow; Edoardo Conte; Ricardo C Cury; Gudrun Feuchtner; Martin Hadamitzky; Yong-Jin Kim; Jonathon Leipsic; Erica Maffei; Hugo Marques; Fabian Plank; Gianluca Pontone; Gilbert L Raff; Alexander R van Rosendael; Todd C Villines; Harald G Weirich; Subhi J Al'Aref; Lohendran Baskaran; Iksung Cho; Ibrahim Danad; Donghee Han; Ran Heo; Ji Hyun Lee; Asim Rivzi; Wijnand J Stuijfzand; Heidi Gransar; Yao Lu; Ji Min Sung; Hyung-Bok Park; Daniel S Berman; Matthew J Budoff; Habib Samady; Leslee J Shaw; Peter H Stone; Renu Virmani; Jagat Narula; James K Min
Journal:  J Am Coll Cardiol       Date:  2018-06-05       Impact factor: 24.094

5.  Differences in the association of total versus local coronary artery calcium with acute coronary syndrome and culprit lesions in patients with acute chest pain: The coronary calcium paradox.

Authors:  Stefan B Puchner; Thomas Mayrhofer; Jakob Park; Michael T Lu; Ting Liu; Pal Maurovich-Horvat; Khristine Ghemigian; Daniel O Bittner; Jerome L Fleg; James E Udelson; Quynh A Truong; Udo Hoffmann; Maros Ferencik
Journal:  Atherosclerosis       Date:  2018-04-17       Impact factor: 5.162

Review 6.  Comprehensive plaque assessment by coronary CT angiography.

Authors:  Pál Maurovich-Horvat; Maros Ferencik; Szilard Voros; Béla Merkely; Udo Hoffmann
Journal:  Nat Rev Cardiol       Date:  2014-04-22       Impact factor: 32.419

Review 7.  Practical utilization of cardiac computed tomography for the success in complex coronary intervention.

Authors:  Kenji Sadamatsu; Masaaki Okutsu; Satoru Sumitsuji; Tomohiro Kawasaki; Sunao Nakamura; Yoshihiro Fukumoto; Kenichi Tsujita; Shinjo Sonoda; Yoshio Kobayashi; Yuji Ikari
Journal:  Cardiovasc Interv Ther       Date:  2021-01-11

Review 8.  Imaging the event-prone coronary artery plaque.

Authors:  Andreas A Giannopoulos; Dominik C Benz; Christoph Gräni; Ronny R Buechel
Journal:  J Nucl Cardiol       Date:  2017-07-06       Impact factor: 5.952

9.  Relationship between coronary calcium score and high-risk plaque/significant stenosis.

Authors:  Kohichiro Iwasaki; Takeshi Matsumoto
Journal:  World J Cardiol       Date:  2016-08-26

Review 10.  Plaque assessment by coronary CT.

Authors:  Bálint Szilveszter; Csilla Celeng; Pál Maurovich-Horvat
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-18       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.